Form 4 for DFTX Definium Therapeutics, Inc.
Accepted 2022-02-17 00:00:00 ET · period of report 2022-02-15 · accession 0001209191-22-011077 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-02-17 | 2022-02-15 | DFTX | Barrow Robert | CEO, Dir | F - Tax | $1.35 | -18.7K | 2.23M | -0.8% | -$25.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Subordinate Voting Shares | 2022-02-15 | F | D | 18,734 | $1.35 | 2,225,979 | D | — | — |